July 23, 2016 4:29 PM ET


Company Overview of Gelesis, Inc.

Key Executives for Gelesis, Inc.

NameBoard RelationshipsTitleAge
Yishai Zohar 15 RelationshipsFounder, Chief Executive Officer, President and Director53
Robert W. Armstrong Ph.D.14 RelationshipsChief Business Officer59
Hassan M. Heshmati M.D.No RelationshipsChief Medical Officer64
Alessandro Sannino Ph.D.No RelationshipsChief Project Scientist44

Gelesis, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John L. LaMattina Ph.D. 92 RelationshipsDecision Options, LLC66
Yishai Zohar 15 RelationshipsGelesis, Inc.53
James Hill Ph.D. 15 RelationshipsGelesis, Inc.--
Allan Geliebter Ph.D. 15 RelationshipsGelesis, Inc.--
Lee M. Kaplan M.D., Ph.D. 39 RelationshipsPureTech Health plc--
View All Board Members

Gelesis, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$436.0K
Compensation as of Fiscal Year 2014
Gelesis, Inc. CEO Compensation
Industry Average


Cleveland BioLabs, Inc. Announces Executive Changes
July 22, 2016 8:22 PM ET
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016
July 22, 2016 8:18 PM ET
ContraFect Corporation Appoints Steven C. Gilman as President and Chief Executive Officer
July 21, 2016 9:32 PM ET
William R. Ringo Intends to Resign from Mirati Therapeutics, Inc.'s Board of Directors
July 21, 2016 8:03 PM ET
Biostage Appoints Harout Dersimonian as Chief Scientific Officer to Oversee Cell Biology, Materials Science and Other Research Underlying its Organ Implant Development
July 21, 2016 12:56 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gelesis, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.